What is a stock summary page? Click here for an overview.
INmune Bio Inc (NAS:INMB) Stock News, Headlines & Updates
INmune Bio Inc Stock News from GuruFocus
- 1
Apr 16, 2025
INmune Bio (INMB) Advances with Positive Patent Opinion for CORDStrom | INMB Stock News
GuruFocus News • 6:32am
INmune Bio Receives Favorable Patentability Opinion for CORDStromâ„¢ Platform Technology | INMB Stock News
GuruFocus News • 6:22am
INmune Bio Receives Favorable Patentability Opinion for CORDStromâ„¢ Platform Technology
Marketwired • 6:00am
Apr 14, 2025
INmune Bio (INMB) Partners to Enhance Cell Therapy Production
GuruFocus News • 11:56am
INmune Bio (INMB) Partners with CGT Catapult for Large-Scale Cell Therapy Manufacturing | INMB Stock News
GuruFocus News • 7:47am
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStromâ„¢ Manufacturing for Commercial Readiness
Marketwired • 7:00am
Apr 01, 2025
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study
Marketwired • 6:00am
Mar 28, 2025
INmune Bio (INMB) Eyes Landmark Developments in 2024 Amid Rising Financial Commitments
GuruFocus News • 5:15am
INmune Bio Inc (INMB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus News • 1:04am
Q4 2024 INmune Bio Inc Earnings Call Transcript
GuruFocus News • 11:04pm
Mar 27, 2025
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
Marketwired • 4:00pm
INmune Bio Inc Reports Q4 EPS of -$0.53 and Revenue of $0.01 Million, Meeting Analyst Estimates
GuruFocus News • 3:51pm
Mar 24, 2025
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
Marketwired • 7:00am
Feb 12, 2025
INmune Bio Opens Phase II in High Dose Cohort of INKmuneâ„¢ Trial in Prostate Cancer
Marketwired • 6:00am
Feb 10, 2025
INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORDStrom for Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Marketwired • 6:00am
Jan 28, 2025
INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news